Medclair AB (NGM:MCLR)

Sweden flag Sweden · Delayed Price · Currency is SEK
2.120
+0.195 (10.13%)
At close: Jul 24, 2025
10.13%
Market Cap174.88M
Revenue (ttm)40.00M
Net Income (ttm)3.46M
Shares Out82.49M
EPS (ttm)0.04
PE Ratio48.42
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume225,663
Average Volume144,797
Openn/a
Previous Close1.925
Day's Rangen/a
52-Week Range1.155 - 2.240
Beta0.67
RSI61.18
Earnings DateAug 8, 2025

About Medclair AB

Medclair AB, a research and development company, specializes in the measurement, collection, and destruction of nitrous oxide (N2O). It offers mobile destruction unit, a solution that can be moved anywhere, where N2O is needed for pain relief; central destruction unit, a system designed for larger N2O destruction volumes; exhalation device that addresses the problem with residual levels of N2O in the patient’s exhalation; collection units for non-frequent use of N2O, and less frequent use or fitting in emergency services vehicles; and Nitrous O... [Read more]

Industry Crude Petroleum and Natural Gas
Founded 2008
Employees 14
Stock Exchange Nordic Growth Market
Ticker Symbol MCLR
Full Company Profile

Financial Performance

In 2024, Medclair AB's revenue was 35.95 million, a decrease of -15.25% compared to the previous year's 42.42 million. Losses were -664,000, -76.16% less than in 2023.

Financial Statements

News

There is no news available yet.